Sustained Clinical Benefit of Pyrotinib Combined with Capecitabine Rescue Therapy After Trastuzumab Resistance in HER2-Positive Advanced Gastric Cancer: A Case Report

BACKGROUND: HER2-positive patients with advanced gastric cancer have a poor prognosis, and trastuzumab-resistant patients lack effective treatment. CASE PRESENTATION: We report a 72-year-old male with HER2-positive gastric cancer. The patient had metastatic tumor during adjuvant chemotherapy after s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Gu, Xiaoqiang, Xu, Jiahua, Chen, Ling, Li, Hongwei, Meng, Dan, Bai, Haoran, Yang, Jinzu, Qian, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257064/
https://www.ncbi.nlm.nih.gov/pubmed/34234467
http://dx.doi.org/10.2147/OTT.S310421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257064/
https://www.ncbi.nlm.nih.gov/pubmed/34234467
http://dx.doi.org/10.2147/OTT.S310421

Ejemplares similares